IonQ (IONQ) stock has been in focus after a strong Q2 update, where management raised full year 2026 revenue guidance and highlighted rapid revenue growth alongside several new quantum collaboration agreements.

Following the Q2 earnings jump, IonQ’s share price has been choppy, with a 30 day share price return of 26.64% but a 90 day share price return that declined 26.37%, while the 3 year total shareholder return remains very large.

If IonQ’s recent move has you looking across quantum computing, this is a good moment to see what else is out there via 24 quantum computing stocks.

After IonQ’s sharp Q2 reaction and mixed recent returns, the debate is simple. Is most of the easy upside already captured in the stock, or does the current valuation still leave meaningful headroom from here?

Most Popular Narrative: 9.7% Undervalued

The most followed IonQ narrative pegs fair value at $48 per share, slightly above the last close at $43.36. This suggests a modest valuation gap that some investors are watching closely.

The biggest risk is still valuation. IonQ’s stock price now implies that the company is very likely to remain one of the long-term winners in quantum. That may happen, but it is not yet proven. A premium multiple on a strong company is one thing, and a valuation that leaves almost no room for disappointment is another.

Want to see what justifies calling IonQ the best funded public quantum platform while still tagging the stock as premium priced? The narrative leans heavily on rapid revenue expansion, a large contracted backlog, and a long runway of reinvestment before profits. Curious how those ingredients combine into a higher fair value than today’s share price.

Result: Fair Value of $48 (UNDERVALUED)

However, IonQ’s fair value story still depends on a rich valuation and a loss-making profile, so any slowdown in revenue momentum or execution could quickly pressure the stock.

Another View On IonQ Valuation

The popular IonQ narrative sees roughly 10% upside to a $48 fair value, yet the simple P/B lens tells a tougher story. IonQ trades at 5.2x book value, which is more expensive than the US Semiconductor industry at 4.9x, but looks cheaper than peer levels at 13.8x. That mix points to real valuation risk if sentiment cools, and potential support if peers stay far richer. Which reference point do you trust more when pricing a still unprofitable quantum stock?

To see how that book value comparison feeds into a wider valuation breakdown, have a look at the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mixed signals around IonQ leave you unsure, this is the time to move quickly, review the data yourself, and weigh both sides. To see the full balance of risks and potential rewards in one place, start with the 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond IonQ?

If IonQ has sharpened your focus on high potential opportunities, do not stop here. Use the Simply Wall Street Screener to quickly spot other stocks that fit your style.

• Target potential upside in quality companies that trade below their estimated worth by checking the 52 high quality undervalued stocks.
• Focus on resilience and aim to sleep easier at night by zeroing in on companies flagged in the 78 resilient stocks with low risk scores.
• Explore lesser known opportunities with solid fundamentals before the crowd catches on by reviewing the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.